![Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3223/MediaObjects/13058_2012_3048_Fig1_HTML.jpg)
Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text
![Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07568-9/MediaObjects/12885_2020_7568_Fig3_HTML.png)
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
![Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffe8c2cb-a482-4e65-95db-70356dde0927/ejh12239-fig-0001-m.jpg)
Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/publication/230850646/figure/fig1/AS:202882147196929@1425382281783/Mechanism-of-action-of-denosumab-compared-to-zoledronic-acid-Notes-RANKL-is-secreted-by.png)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram](https://www.researchgate.net/publication/324912322/figure/fig4/AS:865472643862537@1583356166698/Mechanism-of-action-of-abiraterone-acetate-enzalutamide-radium-223-dichloride_Q640.jpg)
Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram
![Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.0c10764/asset/images/large/nn0c10764_0009.jpeg)
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
![Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways](https://www.spandidos-publications.com/article_images/mmr/25/2/mmr-25-02-12575-g06.jpg)
Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways
![Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00198-007-0540-8/MediaObjects/198_2007_540_Fig8_HTML.gif)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink
![Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article](https://assets.cureus.com/uploads/figure/file/90324/lightbox_56873fb01c7f11ea967fe109aa9b495a-Figure-2_formatted_V1-PME.png)
Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Pilar-Garrido-2/publication/280998264/figure/fig3/AS:284610790477826@1444867908479/figure-fig3_Q320.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07568-9/MediaObjects/12885_2020_7568_Fig1_HTML.png)
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr3.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering](https://pubs.acs.org/cms/10.1021/acsbiomaterials.9b00362/asset/images/large/ab-2019-00362z_0009.jpeg)
Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr1.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr2.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Semantic Scholar Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/366a9fa21911215bb089ce369250ff1587f47dbd/36-Figure9-1.png)
Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Semantic Scholar
![PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02ae3788787adf6a230ad8aee9e0cf256fd0f00b/2-Figure1-1.png)